wada aod9604 status prohibited list just added tirzepatide (mounjaro) to the 2026 Monitoring Program wada aod9604 prohibited status 2025
Description
starting after week 3 misses the peak osteoblast proliferation window
National Library of Medicine
Potential Benefits: Increased Energy Expenditure: Promotes higher resting metabolic rate and caloric burn, even in the absence of physical activity
You need to support it with appropriate diet and training
